The civic record
Read. Follow. Verify.Wisconsin bill extends prescription drug monitoring requirements and board reviews to 2030
Last action · March 23, 2026: Failed to pass pursuant to Senate Joint Resolution 1Sponsors: Barbara Dittrich and 1 other
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Wisconsin Assembly Bill 68 extends two expiring provisions related to the state's by five years to 2030: the requirement for practitioners to review patient records before issuing a prescription, and the requirement for the Controlled Substances Board to conduct quarterly outcome reviews.
Extends mandatory patient record checks by medical practitioners and state oversight evaluations until 2030, affecting prescribers, pharmacists, and patients involved in controlled substance treatments.
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
health care practitioners
Practitioners must continue reviewing patient records in the prescription drug monitoring program before issuing prescription orders until April 1, 2030.
Controlled Substances Board
The board is required to continue conducting and reporting quarterly reviews of the program's outcomes until October 30, 2030.
patients
Patients seeking controlled substance prescriptions remain subject to mandatory record checks by their practitioners through 2030.
Key Facts
- Extends the requirement for health care practitioners or their agents to review patient records before issuing a prescription order from April 1, 2025, to April 1, 2030.
- Extends the Controlled Substances Board's requirement to conduct quarterly reviews evaluating actual versus projected outcomes of the prescription drug monitoring program from October 30, 2025, to October 30, 2030.
- Extends the requirement to publish or report the results of the board's quarterly reviews from October 30, 2025, to October 30, 2030.
Frequently Asked Questions
What does Assembly Bill 68 change about the prescription drug monitoring program?
Who must review patient records before issuing a prescription under these rules?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Failed in the Assembly.
Procedural history
13 actions- Mar 23, 2026HouseFailed to pass pursuant to Senate Joint Resolution 1
- Mar 20, 2025HouseLaid on the table
- Mar 18, 2025HousePlaced on calendar 3-20-2025 by Committee on Rules
- Mar 13, 2025HouseCommitteeReferred to committee on Rules
- Mar 13, 2025HouseFloorReport passage recommended by Committee on Health, Aging and Long-Term Care, Ayes 15, Noes 0
- Mar 13, 2025HouseExecutive action taken
Show 7 earlier actions
- Mar 12, 2025HouseRepresentative Moore Omokunde added as a coauthor
- Mar 12, 2025HousePublic hearing held
- Mar 11, 2025HouseRepresentative Stubbs added as a coauthor
- Mar 4, 2025HouseRepresentative Subeck added as a coauthor
- Feb 26, 2025HouseFiscal estimate received
- Feb 24, 2025HouseIntroducedRead first time and referred to Committee on Health, Aging and Long-Term Care
- Feb 24, 2025HouseIntroducedIntroduced by Representative Dittrich; cosponsored by Senator Testin
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Connected Entities
Sources
docs.legis.wisconsin.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 45)
- Controversy15Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz10Current news / social attention level
Publisher tools
